Nama's AI scorecard currently rates Cabot Buy (6.0 out of 10), a call computed from its profitability, cash generation, growth, valuation and balance sheet. It is a research reading, not investment advice.

What is CBT's P/E ratio?

Cabot trades at a trailing price-to-earnings ratio of 11.1.

When does CBT report earnings?

Cabot's next scheduled report is on Feb 1, 2027. Analysts expect EPS of $1.54.

What is the CBT price target?

The median analyst price target from 6 analysts is $87.50, with a range of $78.00 – $98.00.

Is CBT Shariah compliant?

Nama's AAOIFI-style screen reads Cabot as Shariah Compliant. Passes our debt, cash and income screen; not a scholar's ruling.

Does CBT pay a dividend?

Yes — Cabot's dividend yield is 2.6%.

Nama Insights

Cabot (CBT)

Basic Materials · Specialty Chemicals · NYSE

Cabot (CBT) is a Basic Materials company in the Specialty Chemicals industry. It has a market capitalization of $3.65B, a trailing price-to-earnings ratio of 11.1 and a free-cash-flow yield of 10.2%. Over the most recent reported fiscal year, revenue declined 7.0% and free cash flow per share fell 10.9%. Nama's AI scorecard rates it Buy, 6.0 out of 10. On 12-month momentum it ranks in the leading band of its market.

AI scorecard

Buy · 6.0/10

Positive, at the low end of Buy. As of Nov 7, 2026.

Momentum

Leading · +27.1% over 12 months ex. last

Top 20% of its market on the past year's steady rise.

Shariah screen

Shariah Compliant

Passes our debt, cash and income screen; not a scholar's ruling.

Off its high

-39.5%

How far the last close sits under the highest price of the past five years.

Market cap	$3.65B
Trailing P/E	11.1
Price / book	2.3
Price / sales	1.0
FCF yield	10.2%
Dividend yield	2.6%
Gross margin	22.7%
Operating margin	13.6%
Net margin	5.2%
Revenue growth (YoY)	-7.0%
Revenue growth (3-yr annual)	-4.9%
EPS growth (YoY)	+2.8%
FCF/share growth (YoY)	-10.9%
Beta	0.8
Exchange	NYSE
Sector	Basic Materials
Industry	Specialty Chemicals

CBT earnings

Next report: Feb 1, 2027 (Q1 2027, EPS estimate $1.54). Beat the EPS estimate in 4 of 4 recent quarters.

Quarter	Reported	EPS	Estimate	Surprise	Revenue
Q4 2026	Nov 2, 2026	$1.61	$1.54	+4.5%	—
Q3 2026	Aug 3, 2026	$1.67	$1.66	+0.6%	$982.00M
Q2 2026	May 5, 2026	$1.61	$1.47	+9.5%	$904.00M
Q1 2026	Feb 3, 2026	$1.53	$1.38	+10.9%	$849.00M

CBT analyst price target

Median target $87.50 from 6 analysts, ranging $78.00 – $98.00.

Specialty Chemicals peers

Ticker	Company	Market cap	P/E
LIN	Linde	$236.54B	30.9
ECL	Ecolab	$84.33B	37.4
SHW	Sherwin-Williams	$83.13B	28.9
APD	Air Products and Chemicals	$67.88B	22.7
PPG	PPG Industries	$27.03B	15.7
IFF	International Flavors & Fragrances	$20.69B	22.3
LYB	LyondellBasell Industries	$19.63B	8.6
DD	DuPont de Nemours	$19.42B	20.9

Explore live CBT data on Nama Insights →

Recent Congressional trades

Cabot trades disclosed by members of the US House and Senate under the STOCK Act. See the full Congress trades board →

Member	Chamber	Trade	Amount	Disclosed
Susan M Collins	Senate	Sell	$1,001 - $15,000	—

CBT FAQ

Is CBT a buy?: Nama's AI scorecard currently rates Cabot Buy (6.0 out of 10), a call computed from its profitability, cash generation, growth, valuation and balance sheet. It is a research reading, not investment advice.
What is CBT's P/E ratio?: Cabot trades at a trailing price-to-earnings ratio of 11.1.
When does CBT report earnings?: Cabot's next scheduled report is on Feb 1, 2027. Analysts expect EPS of $1.54.
What is the CBT price target?: The median analyst price target from 6 analysts is $87.50, with a range of $78.00 – $98.00.
Is CBT Shariah compliant?: Nama's AAOIFI-style screen reads Cabot as Shariah Compliant. Passes our debt, cash and income screen; not a scholar's ruling.
Does CBT pay a dividend?: Yes — Cabot's dividend yield is 2.6%.